Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Molecular and Cellular Biology

• Publication date

  1995-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.15.4.1968PMID 7891691PMCID PMC230423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells.

  1994cited by this paper
• Retroviral vectors.

  1994cited by this paper
• Application of LacZ gene fusions to postimplantation development.

  1993cited by this paper
• Site-specific recombinases: tools for genome engineering.

  1993cited by this paper
• Application of LacZ gene fusions to postimplantation development.

  1993cited by this paper
• Capture of a cellular transcriptional unit by a retrovirus: mode of provirus activation in embryonal carcinoma cells

  1992cited by this paper
• Gene replacement with one-sided homologous recombination

  1992cited by this paper
• Site-specific recombination determined by I-SceI, a mitochondrial group I intron-encoded endonuclease expressed in the yeast nucleus.

  1992cited by this paper
• Repair of deletions and double-strand gaps by homologous recombination in a mammalian in vitro system

  1991cited by this paper
• Cleavage of yeast and bacteriophage T7 genomes at a single site using the rare cutter endonuclease I-Sce I

  1991cited by this paper
• Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

  1991cited by this paper
• Repair of double-stranded DNA breaks by homologous DNA fragments during transfer of DNA into mouse L cells

  1990cited by this paper
• Intermolecular recombination between DNAs introduced into mouse L cells is mediated by a nonconservative pathway that leads to crossover products

  1990cited by this paper
• Altering the genome by homologous recombination.

  1989cited by this paper
• Retroviruses.

  1988cited by this paper
• Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes

  1988cited by this paper
• Phleomycin resistance as a dominant selectable marker in CHO cells

  1988influential reference
• Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.

  1988cited by this paper
• Intermolecular homologous recombination between transfected sequences in mammalian cells is primarily nonconservative

  1987cited by this paper
• Mouse teratocarcinoma cells.

  1987cited by this paper
• [6] Mouse teratocarcinoma cells

  1987cited by this paper
• Double-strand gap repair results in homologous recombination in mouse L cells.

  1986cited by this paper
• Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination

  1985cited by this paper
• An intron-encoded protein is active in a gene conversion process that spreads an intron into a mitochondrial gene.

  1985cited by this paper
• Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

  1983cited by this paper
• The double-strand-break repair model for recombination.

  1983cited by this paper
• RNA tumor viruses

  1982cited by this paper

• Unlocking the potential of CRISPR-associated transposons: from structural to functional insights.

  2025cites this paper
• The Potential of NGTs to Overcome Constraints in Plant Breeding and Their Regulatory Implications

  2025cites this paper
• Transgene integration in mammalian cells: The tools, the challenges, and the future.

  2025cites this paper
• Advancements in genome editing tools for genetic studies and crop improvement

  2025cites this paper
• A CRISPR‐Cas9‐based system for the dose‐dependent study of DNA double‐strand break sensing and repair

  2025cites this paper
• Advances in hepatocellular carcinoma drug resistance models

  2024cites this paper
• Removal of TREX1 activity enhances CRISPR–Cas9-mediated homologous recombination

  2024cites this paper
• Exploring the potential of nanomedicine for gene therapy across the physicochemical and cellular barriers

  2024cites this paper
• Identification and Validation of New DNA-PKcs Inhibitors through High-Throughput Virtual Screening and Experimental Verification

  2024cites this paper
• Harnessing the evolving CRISPR/Cas9 for precision oncology

  2024cites this paper
• CRISPR Technology Acts as a Dual-Purpose Tool in Pig Breeding: Enhancing Both Agricultural Productivity and Biomedical Applications

  2024cites this paper
• Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.

  2023cites this paper
• Green revolution to genome revolution: driving better resilient crops against environmental instability

  2023cites this paper
• Rare immune diseases paving the road for genome editing-based precision medicine

  2023cites this paper
• Advances in the application of CRISPR/Cas9 system in the study of hematologic diseases and cancer

  2023cites this paper
• Genome Editing and Diabetic Cardiomyopathy.

  2023cites this paper
• Transgenesis and Genome Engineering: A Historical Review.

  2023cites this paper
• Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies.

  2023cites this paper
• Functional genomic and transformation resources for commercially important red macroalgae (Rhodophyta)

  2023cites this paper
• Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells

  2023cites this paper
• A Novel Breakthrough in Leptospira spp. Mutagenesis: Knockout by Combination of CRISPR/Cas9 and Non-homologous End-Joining Systems

  2022influential citation
• Historical DNA Manipulation Overview.

  2022cites this paper
• Improvements in the genetic editing technologies: CRISPR-Cas and beyond.

  2022cites this paper
• Advances in Renal Cell Carcinoma Drug Resistance Models

  2022cites this paper
• A Curative DNA Code for Hematopoietic Defects Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System

  2022cites this paper
• The Role of Recombinant AAV in Precise Genome Editing

  2022cites this paper
• Speciation and adaptation research meets genome editing

  2022cites this paper
• Genome Editing in Bacteria: CRISPR-Cas and Beyond

  2021cites this paper
• A short, idiosyncratic history of genome editing

  2021cites this paper
• Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

  2021cites this paper
• Genome-edited Camelina sativa with a unique fatty acid content and its potential impact on ecosystems

  2021cites this paper
• Practical Approaches for Knock-Out Gene Editing in Pigs

  2021cites this paper
• History of genome editing: From meganucleases to CRISPR

  2021cites this paper
• Gene Targeting Facilitated by Engineered Sequence-Specific Nucleases: Potential Applications for Crop Improvement

  2021cites this paper
• Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing

  2021cites this paper
• The evolution and history of gene editing technologies.

  2021cites this paper
• Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects

  2021cites this paper
• Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective

  2021cites this paper
• The history of Salpingoeca rosetta as a model for reconstructing animal origins.

  2021cites this paper
• Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions

  2021cites this paper
• Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering

  2021cites this paper
• Genome Editing of Eukarya

  2021cites this paper
• The clinical potential of gene editing as a tool to engineer cell-based therapeutics

  2020cites this paper
• Applications of Functional Genomics for Drug Discovery

  2020cites this paper
• Marek’s disease virus: from novel viral interleukin-8 (vIL-8) splice variants to inhibition with CRISPR/Cas9

  2020cites this paper
• Leveraging DNA Damage Response Pathways to Enhance the Precision of CRISPR-Mediated Genome Editing

  2020cites this paper
• Ethical considerations of gene editing and genetic selection

  2020cites this paper
• Genome Editing of the SNAI1 Gene in Rhabdomyosarcoma: A Novel Model for Studies of Its Role

  2020cites this paper
• Challenges and Advances in Genome Editing Technologies in Streptomyces

  2020cites this paper
• Gene editing technology for improving life quality: A dream coming true?

  2020cites this paper
• Genome editing enables reverse genetics of multicellular development in the choanoflagellate Salpingoeca rosetta

  2020cites this paper
• Genome Editing by Targeted Nucleases and the CRISPR/Cas Revolution

  2020cites this paper
• Broadening the GMO risk assessment in the EU for genome editing technologies in agriculture

  2020cites this paper
• Development and Application of CRISPR-Mediated Genetic Screening in Oncology

  2020cites this paper
• ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

  2020cites this paper
• Monitoring Double-Strand Break Repair of Trinucleotide Repeats Using a Yeast Fluorescent Reporter Assay.

  2020cites this paper
• The best CRISPR/Cas9 versus RNA interference approaches for Arabinogalactan proteins’ study

  2020cites this paper
• Emerging Genome Engineering Tools in Crop Research and Breeding.

  2020cites this paper
• Assessing Public Opinion on CRISPR-Cas9: Combining Crowdsourcing and Deep Learning

  2020cites this paper
• USE OF GENOME EDITING TECHNOLOGIES: ACHIEVEMENTS AND FURURE PROSPECTS

  2019cites this paper
• Future Science Group

  2019cites this paper
• Delivery of CRISPR/Cas9 for therapeutic genome editing

  2019cites this paper
• Estratégias para o aumento na eficiência de produção de suínos geneticamente modificados

  2019cites this paper
• Sheep and Goat Genome Engineering: From Random Transgenesis to the CRISPR Era

  2019cites this paper
• Ride the Tide: Observing CRISPR/Cas9 genome editing by the numbers

  2019cites this paper
• CRISPR-Cas Technology as a Tool to Create Animal Models for Biomedical Research

  2019cites this paper
• Gene Editing Based Hearing Impairment Research and Therapeutics.

  2019cites this paper
• Gene silencing based on RNA-guided catalytically inactive Cas9 (dCas9): a new tool for genetic engineering in Leptospira

  2019cites this paper
• New Possibilities on the Horizon: Genome Editing Makes the Whole Genome Accessible for Changes

  2019cites this paper
• Review on CRISPR/Cas-9 Gene Editing Technology and Its Potential Clinical Application

  2019influential citation
• CRISPR/Cas9-based knockout pipeline for reverse genetics in mammalian cell culture.

  2019cites this paper
• A Practical Guide to Genome Editing Using Targeted Nuclease Technologies.

  2019cites this paper
• CRISPR/Cas system: An emerging technology in stem cell research

  2019cites this paper
• CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing

  2019influential citation
• Creating cell and animal models of human disease by genome editing using CRISPR/Cas9

  2019cites this paper
• Combining Crowdsourcing and Deep Learning to Assess Public Opinion on CRISPR-Cas9

  2019cites this paper
• Genome analysis and engineering of industrial lager brewing yeasts

  2019influential citation
• CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

  2019cites this paper
• Efficient gene correction of an aberrant splice site in β‐thalassaemia iPSCs by CRISPR/Cas9 and single‐strand oligodeoxynucleotides

  2019cites this paper
• A New Class of Medicines through DNA Editing

  2019cites this paper
• The current landscape for the treatment of mitochondrial disorders.

  2018cites this paper
• CRISPR/Cas9-mediated gene targeting in Arabidopsis using sequential transformation

  2018cites this paper
• Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing.

  2018cites this paper
• Editing of Genomic TNFSF9 by CRISPR-Cas9 Can Be Followed by Re-Editing of Its Transcript

  2018cites this paper
• Zinc Finger Proteins

  2018cites this paper
• Non-transgenic Approach to Deliver ZFNs in Seeds for Targeted Genome Engineering.

  2018cites this paper
• The molecular biology of sickle cell anaemia

  2018cites this paper
• Plant Biotechnology Applications of Zinc Finger Technology.

  2018cites this paper
• Genome Editing and Engineering

  2018cites this paper
• CHARACTERIZATION OF MOLECULAR MECHANISMS DRIVING EPIGENETIC CONVERSION AND PHENOTYPE SWITCH OF FIBROBLASTS INTO INSULIN SECRETING CELLS

  2018cites this paper
• Enhancing the Efficiency of CRISPR/Cas9 Precise Gene Editing for Cystic Fibrosis Gene Therapy

  2018cites this paper
• Correction of the ΔF508 mutation in the CFTR Gene by CRISPR/Cas9 system

  2018cites this paper
• High-throughput creation and functional profiling of DNA sequence variant libraries using CRISPR/Cas9 in yeast

  2018cites this paper
• DNA Nucleases and their Use in Livestock Production

  2018cites this paper
• Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation

  2018cites this paper
• Initiation of homologous recombination at DNA nicks

  2018cites this paper
• Site-directed genome modification with engineered zinc finger proteins

  2018cites this paper
• Engineering altered protein–DNA recognition specificity

  2018cites this paper
• Cholesterol metabolism and statin effects on an FH class II LDL-receptor mutation.

  2018cites this paper
• Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech

  2018influential citation